The Technical AnalystExchange: SIX
BB Biotech AG Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.24% CHF41.35
America/New_York / 30 apr 2024 @ 11:31
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 267.88 mill |
| EPS: | -3.77 |
| P/E: | -10.97 |
| Earnings Date: | Apr 26, 2024 |
| SharesOutstanding: | 54.85 mill |
| Avg Daily Volume: | 0.0695 mill |
| RATING 2024-04-30 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -10.97 | sector: PE 25.29 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -10.97 | industry: PE -3.18 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CHF-7.08 (-117.12%) CHF-48.43 |
| Date: 2024-05-01 |
| Expected Trading Range (DAY) |
|---|
|
CHF 40.23 - 42.48 ( +/- 2.72%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CHF41.35 (0.24% ) |
| Volume | 0.0564 mill |
| Avg. Vol. | 0.0695 mill |
| % of Avg. Vol | 81.15 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BION.SW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BION.SW
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.